Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | President and CFO | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 26,661 |
Ending reported balance
After 2026-09-16 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-09-15 · Grant · Acquired 4,088 · Balance 28,001 F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Row 2 · 2026-09-15 · Tax withholding · Disposed 249 · Balance 27,752 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 3 · 2026-09-15 · Tax withholding · Disposed 275 · Balance 27,477 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 4 · 2026-09-15 · Tax withholding · Disposed 457 · Balance 27,020 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 5 · 2026-09-16 · Tax withholding · Disposed 359 · Balance 26,661 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2026 Filed Sep 17, 2026 20:22 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 359 | $272.46 | $97,813.14 |
DisclosureSEC source: 0001915955-26-000003 · wk-form4_1789676517.xml · nonDerivative · entry 5 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,661 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 457 | $275.09 | $125,716.13 |
DisclosureSEC source: 0001915955-26-000003 · wk-form4_1789676517.xml · nonDerivative · entry 4 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,020 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 275 | $275.09 | $75,649.75 |
DisclosureSEC source: 0001915955-26-000003 · wk-form4_1789676517.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,477 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 249 | $275.09 | $68,497.41 |
DisclosureSEC source: 0001915955-26-000003 · wk-form4_1789676517.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,752 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,088 | $275.09 | $1,124,567.92 |
DisclosureSEC source: 0001915955-26-000003 · wk-form4_1789676517.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,001 F1 · kind: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 76 | $311.40 | $23,666.40 |
DisclosureSEC source: 0001628280-26-018536 · wk-form4_1773764601.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,913 F3 · shares: Ms. Fitzpatrick surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,439 | $311.40 | $759,504.60 |
DisclosureSEC source: 0001628280-26-018536 · wk-form4_1773764601.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,989 F2 · shares: Ms. Fitzpatrick surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 5,504 | $311.40 | $1,713,945.60 |
DisclosureSEC source: 0001628280-26-018536 · wk-form4_1773764601.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,428 F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025. Read SEC document |
| September 16, 2025 Filed Sep 17, 2025 17:48 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 379 | $259.83 | $98,475.57 |
DisclosureSEC source: 0001915955-25-000005 · wk-form4_1758131329.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,924 F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:48 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,348 | $258.83 | $1,125,392.84 |
DisclosureSEC source: 0001915955-25-000005 · wk-form4_1758131329.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,303 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:48 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 639 | $258.83 | $165,392.37 |
DisclosureSEC source: 0001915955-25-000005 · wk-form4_1758131329.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,955 F1 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:17 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 78 | $258.68 | $20,177.04 |
DisclosureSEC source: 0001156375-25-000047 · wk-form4_1742314672.xml · nonDerivative · entry 5 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,594 F4 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:17 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 492 | $258.68 | $127,270.56 |
DisclosureSEC source: 0001156375-25-000047 · wk-form4_1742314672.xml · nonDerivative · entry 4 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,672 F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:17 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,110 | $258.68 | $287,134.80 |
DisclosureSEC source: 0001156375-25-000047 · wk-form4_1742314672.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,164 F3 · shares: Represents shares earned from a March 2022 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:17 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 152 | $258.68 | $39,319.36 |
DisclosureSEC source: 0001156375-25-000047 · wk-form4_1742314672.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,054 F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:17 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 341 | $258.68 | $88,209.88 |
DisclosureSEC source: 0001156375-25-000047 · wk-form4_1742314672.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,206 F1 · shares: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 23:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,604 | $218.53 | $787,582.12 |
DisclosureSEC source: 0001156375-24-000177 · wk-form4_1726614684.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,865 Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:00 UTC Amendment | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,604 | $218.53 | $787,582.12 |
DisclosureSEC source: 0001156375-24-000182 · wk-form4a_1726689610.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,865 Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 23:11 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 754 | $216.99 | $163,610.46 |
DisclosureSEC source: 0001156375-24-000177 · wk-form4_1726614684.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,261 F1 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2024. Read SEC document |
| September 15, 2024 Filed Sep 18, 2024 20:00 UTC Amendment | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 754 | $216.99 | $163,610.46 |
DisclosureSEC source: 0001156375-24-000182 · wk-form4a_1726689610.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,261 F1 · kind: This Form 4 is being amended to include the correct transaction code which was incorrectly reported on the original filing due to clerical error. F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:22 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 81 | $217.50 | $17,617.50 |
DisclosureSEC source: 0001156375-24-000041 · wk-form4_1710861745.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,015 F3 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:22 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 248 | $217.50 | $53,940.00 |
DisclosureSEC source: 0001156375-24-000041 · wk-form4_1710861745.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,096 F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:22 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 559 | $217.50 | $121,582.50 |
DisclosureSEC source: 0001156375-24-000041 · wk-form4_1710861745.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,344 F1 · shares: Represents shares earned from a 2020 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2021-2023. Read SEC document |
| September 16, 2023 Filed Sep 18, 2023 22:12 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 71 | $206.82 | $14,684.22 |
DisclosureSEC source: 0001156375-23-000156 · wk-form4_1695075131.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,785 F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2023. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:12 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 479 | $206.82 | $99,066.78 |
DisclosureSEC source: 0001156375-23-000156 · wk-form4_1695075131.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,856 F1 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2023. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:12 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,900 | $206.82 | $599,778.00 |
DisclosureSEC source: 0001156375-23-000156 · wk-form4_1695075131.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,335 Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 17:51 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 171 | $182.67 | $31,236.57 |
DisclosureSEC source: 0001156375-23-000037 · wf-form4_167907548514433.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,435 F1 · shares: Ms. Lynne Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2023. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 22:32 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 75 | $191.56 | $14,367.00 |
DisclosureSEC source: 0001156375-22-000277 · wf-form4_166362650737845.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,606 F2 · shares: Ms. Lynne Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:32 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000277 · wf-form4_166362650737845.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,681 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:32 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 200 | $190.77 | $38,154.00 |
DisclosureSEC source: 0001156375-22-000277 · wf-form4_166362650737845.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,929 F1 · shares: Ms. Lynne Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2022. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 21:51 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000245 · wf-form4_166327866486953.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,129 F1 · shares: Ms. Lynne Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. Read SEC document |
| September 14, 2022 Filed Sep 19, 2022 23:08 UTC Amendment | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 94 | $191.30 | $17,982.20 |
DisclosureSEC source: 0001156375-22-000288 · wf-form4a_166362887289928.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,129 F1 · shares: Ms. Lynne Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. F2 · price: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:46 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,020 | $232.00 | $236,640.00 |
DisclosureSEC source: 0001156375-22-000139 · wf-form4_164754999520950.xml · nonDerivative · entry 3 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,223 F3 · shares: On March 15, 2022, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the restricted share agreement. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:46 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 68 | $232.00 | $15,776.00 |
DisclosureSEC source: 0001156375-22-000139 · wf-form4_164754999520950.xml · nonDerivative · entry 2 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,203 F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:46 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 231 | $232.00 | $53,592.00 |
DisclosureSEC source: 0001156375-22-000139 · wf-form4_164754999520950.xml · nonDerivative · entry 1 Fitzpatrick Lynne · CIK 0001915955 · Sr MD Deputy CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,271 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.